DE69309044T2 - Behandlung von asthma - Google Patents
Behandlung von asthmaInfo
- Publication number
- DE69309044T2 DE69309044T2 DE69309044T DE69309044T DE69309044T2 DE 69309044 T2 DE69309044 T2 DE 69309044T2 DE 69309044 T DE69309044 T DE 69309044T DE 69309044 T DE69309044 T DE 69309044T DE 69309044 T2 DE69309044 T2 DE 69309044T2
- Authority
- DE
- Germany
- Prior art keywords
- asthma
- treatment
- eosinophils
- polypeptide
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70542—CD106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82176892A | 1992-01-13 | 1992-01-13 | |
US821768 | 1992-01-13 | ||
PCT/US1993/000030 WO1993013798A1 (en) | 1992-01-13 | 1993-01-12 | Treatment for asthma |
Publications (3)
Publication Number | Publication Date |
---|---|
DE69309044D1 DE69309044D1 (de) | 1997-04-24 |
DE69309044T2 true DE69309044T2 (de) | 1997-09-25 |
DE69309044T3 DE69309044T3 (de) | 2004-12-23 |
Family
ID=25234272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69309044T Expired - Lifetime DE69309044T3 (de) | 1992-01-13 | 1993-01-12 | Behandlung von asthma |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0626861B2 (de) |
JP (4) | JPH07506091A (de) |
AT (1) | ATE150319T1 (de) |
CA (1) | CA2127462C (de) |
DE (1) | DE69309044T3 (de) |
DK (1) | DK0626861T4 (de) |
ES (1) | ES2102009T5 (de) |
GR (1) | GR3023203T3 (de) |
HK (1) | HK1007682A1 (de) |
WO (1) | WO1993013798A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932214A (en) * | 1994-08-11 | 1999-08-03 | Biogen, Inc. | Treatment for inflammatory bowel disease with VLA-4 blockers |
US5843438A (en) | 1992-11-13 | 1998-12-01 | Board Of Regents University Of Washington | Peripheralization of hematopoietic stem cells |
DE69419721T2 (de) * | 1993-01-12 | 2000-04-27 | Biogen Inc | Rekombinante anti-vla4 antikörpermoleküle |
JP3593343B2 (ja) * | 1993-02-09 | 2004-11-24 | バイオジェン インコーポレイテッド | インシュリン依存型糖尿病の治療 |
AU727187B2 (en) * | 1993-02-09 | 2000-12-07 | Biogen Idec Ma Inc. | Treatment for insulin dependent diabetes |
ZA947006B (en) * | 1993-09-15 | 1995-05-02 | Univ Emory | Method of inhibiting binding of reticulocytes to endothelium by interfering with vla-4/vcam-1 interactions |
PL323130A1 (en) * | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
DE19647381A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
DE19741235A1 (de) | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19751251A1 (de) | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US7618630B2 (en) | 1998-09-14 | 2009-11-17 | Board Of Regents, The University Of Texas System | Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
PT1113810E (pt) | 1998-09-14 | 2009-03-10 | Univ Texas | Processos de tratamento de mieloma múltiplo e reabsorção óssea induzida por mieloma utilizando antagonistas da ligação do receptor de integrina |
SK287328B6 (sk) | 1999-04-22 | 2010-07-07 | Biogen Idec Ma Inc. | Použitie kompozície obsahujúcej homológ protilátky, ktorý je antagonistom interakcie medzi integrínom nesúcim podjednotku alfa4 a ligandom pre integrín nesúci podjednotku alfa4 |
DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
SI1488806T1 (sl) | 1999-06-01 | 2016-02-29 | Biogen Ma Inc. | Blokirno monoklonsko protitelo proti vla-1 in njegova uporaba za zdravljenje žilnih obolenj |
DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
ES2347532T3 (es) | 2001-04-13 | 2010-11-02 | Biogen Idec Ma Inc. | Anticuerpos contra vla-1. |
DE10137595A1 (de) | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
JP4470219B2 (ja) | 2002-02-20 | 2010-06-02 | 味の素株式会社 | 新規フェニルアラニン誘導体 |
US7345049B2 (en) | 2003-12-22 | 2008-03-18 | Ajinomoto Co., Inc. | Phenylalanine derivatives |
GB0521621D0 (en) * | 2005-10-24 | 2005-11-30 | Domantis Ltd | Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases |
BRPI0712607A8 (pt) | 2006-05-25 | 2019-06-04 | Biogen Idec Inc | métodos de tratamento de acidente vascular cerebral |
WO2008103378A2 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
KR20110008086A (ko) | 2008-04-11 | 2011-01-25 | 메리맥 파마슈티컬즈, 인크. | 인간 혈청 알부민 링커 및 그 콘쥬게이트 |
PT3202789T (pt) | 2010-04-16 | 2020-06-16 | Biogen Ma Inc | Anticorpos anti-vla-4 |
JP6345123B2 (ja) | 2012-02-16 | 2018-06-20 | サンタラス, インコーポレイテッド | 抗vla1(cd49a)抗体医薬組成物 |
IL294921A (en) | 2020-01-24 | 2022-09-01 | Pfizer | Antibodies against E-selectin, preparations and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) † | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
GB8607679D0 (en) † | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
IL95501A (en) † | 1989-09-01 | 1997-04-15 | Hutchinson Fred Cancer Res | Inhibition by antibodies of lymphocyte adherence to vascular endothelium utilizing an extracellular matrix receptor-ligand interaction, and pharmaceutical compositions containing said antibodies |
DK162890D0 (da) | 1990-07-06 | 1990-07-06 | Novo Nordisk As | Polypeptid |
-
1993
- 1993-01-12 DK DK93902914T patent/DK0626861T4/da active
- 1993-01-12 WO PCT/US1993/000030 patent/WO1993013798A1/en active IP Right Grant
- 1993-01-12 CA CA002127462A patent/CA2127462C/en not_active Expired - Lifetime
- 1993-01-12 ES ES93902914T patent/ES2102009T5/es not_active Expired - Lifetime
- 1993-01-12 AT AT93902914T patent/ATE150319T1/de active
- 1993-01-12 JP JP5512512A patent/JPH07506091A/ja not_active Withdrawn
- 1993-01-12 EP EP93902914A patent/EP0626861B2/de not_active Expired - Lifetime
- 1993-01-12 DE DE69309044T patent/DE69309044T3/de not_active Expired - Lifetime
-
1997
- 1997-04-21 GR GR970400864T patent/GR3023203T3/el unknown
-
1998
- 1998-06-26 HK HK98106927A patent/HK1007682A1/xx not_active IP Right Cessation
-
2002
- 2002-09-30 JP JP2002286910A patent/JP4590152B2/ja not_active Expired - Lifetime
-
2006
- 2006-08-10 JP JP2006218925A patent/JP2006316070A/ja not_active Withdrawn
-
2010
- 2010-07-27 JP JP2010168709A patent/JP2010285444A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ES2102009T3 (es) | 1997-07-16 |
JP2003176239A (ja) | 2003-06-24 |
DK0626861T3 (da) | 1997-09-22 |
JP4590152B2 (ja) | 2010-12-01 |
DE69309044D1 (de) | 1997-04-24 |
ATE150319T1 (de) | 1997-04-15 |
EP0626861A1 (de) | 1994-12-07 |
WO1993013798A1 (en) | 1993-07-22 |
GR3023203T3 (en) | 1997-07-30 |
HK1007682A1 (en) | 1999-04-23 |
AU665232B2 (en) | 1995-12-21 |
JPH07506091A (ja) | 1995-07-06 |
AU3431793A (en) | 1993-08-03 |
EP0626861B2 (de) | 2004-04-28 |
EP0626861B1 (de) | 1997-03-19 |
DK0626861T4 (da) | 2004-08-16 |
ES2102009T5 (es) | 2004-12-16 |
CA2127462A1 (en) | 1993-07-22 |
CA2127462C (en) | 1999-03-23 |
DE69309044T3 (de) | 2004-12-23 |
JP2006316070A (ja) | 2006-11-24 |
JP2010285444A (ja) | 2010-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69309044D1 (de) | Behandlung von asthma | |
DE69407758D1 (de) | Antikörper zur behandlung von insulinabhängigen diabetes | |
DE69227041T2 (de) | Expression und reinigung von rekombinantem, löslichem gewebefaktor | |
PT723538E (pt) | Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas | |
DE69211403T2 (de) | Multifunktionelle wasserdispergierbare Verknüpfungsmittel | |
AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
DE69634726D1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
IT8622630A0 (it) | Anticorpi monoclonali crossreattivi e cross-protettivi contro sierotipi di p. aeruginosa. | |
GR3026519T3 (en) | New method of treating depression | |
ATE220688T1 (de) | Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen | |
FI854383A0 (fi) | Foerfarande foer avspaltning av peptider och proteiner av metionyl-bindning. | |
DE68921229T2 (de) | Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein. | |
DK0646176T3 (da) | Levering og ekspression af et hybridoverfladeprotein på overfladen af grampositive bakterier | |
DE69029471D1 (de) | Wiedergewinnungsverfahren von mikrobiell erzeugtem chymosin | |
DE69330268D1 (de) | Hämoregulierende peptide | |
DK0383599T3 (da) | Protein-anticancermiddel | |
DE59310073D1 (de) | Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen | |
EP0235904A3 (de) | Behandlung von Allergie mit Thymopentin | |
ATE107165T1 (de) | Verwendung von macrolactonen als antiallergica. | |
DE68909118D1 (de) | Verfahren zur Ausscheidung von 2,6-Dimethylnaphthalin. | |
DE69012034D1 (de) | Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa. | |
DE68905673T2 (de) | Verfahren zur Ausscheidung von 2,6-Dimethylnaphthalin. | |
DE3784891T2 (de) | Verfahren zur Isolierung von säurestabilen, biologisch aktiven Proteinen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8366 | Restricted maintained after opposition proceedings | ||
R071 | Expiry of right |
Ref document number: 626861 Country of ref document: EP |